Citations (46)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Silvano Sozzani, Maria P. Abbracchio, Vito Annese, Silvio Danese, Ornella De Pità, Giovambattista De Sarro, Sabatino Maione, Ignazio Olivieri, Aurora Parodi & Piercarlo Sarzi-Puttini. (2014) Chronic inflammatory diseases: Do immunological patterns drive the choice of biotechnology drugs? A critical review. Autoimmunity 47:5, pages 287-306.
Read now
Read now
Hong Yang & Arthur Kavanaugh. (2014) Adverse effects of golimumab in the treatment of rheumatologic diseases. Expert Opinion on Drug Safety 13:1, pages 103-112.
Read now
Read now
Sheikh Fayaz Ahmad, Sarang Bani, Phalisteen Sultan, Sheikh Abid Ali, Saleh A. Bakheet, Sabry M. Attia & Adel R. A. Abd-Allah. (2013) TNF-α inhibitory effect of Euphorbia hirta in rats. Pharmaceutical Biology 51:4, pages 411-417.
Read now
Read now
David J. Shealy, Ann Cai, Kim Staquet, Audrey Baker, Eilyn R. Lacy, Laura Johns, Omid Vafa, George Gunn, Susan Tam, Sarah Sague, Dana Wang, Mike Brigham-Burke, Paul Dalmonte, Eva Emmell, Bill Pikounis, Peter J. Bugelski, Honghui Zhou, Bernard J. Scallon & Jill M. Giles-Komar. (2010) Characterization of golimumab, a human monoclonal antibody specific for human tumor necrosis factor α. mAbs 2:4, pages 428-439.
Read now
Read now
Kavita V. Nair, Boxiong Tang, Jill Van Den Bos, Vicki Zhang, Joseph J. Saseen, Ahmad Naim & Mirza Rahman. (2009) Categorization of infliximab dose changes and healthcare utilization and expenditures for patients with rheumatoid arthritis in commercially insured and Medicare-eligible populations. Current Medical Research and Opinion 25:2, pages 303-314.
Read now
Read now
Martin Aringer & Josef S Smolen. (2008) Efficacy and safety of TNF-blocker therapy in systemic lupus erythematosus. Expert Opinion on Drug Safety 7:4, pages 411-419.
Read now
Read now
Articles from other publishers (40)
Xiaoyu Xu, Linshuang Wang, Qian Chen, Zikang Wang, Xun Pan, Xike Peng, Miao Wang, Dongfeng Wei, Yanping Li & Bin Wu. (2022) Decoding the Mechanism of CheReCunJin Formula in Treating Sjögren’s Syndrome Based on Network Pharmacology and Molecular Docking. Evidence-Based Complementary and Alternative Medicine 2022, pages 1-14.
Crossref
Crossref
Thilina U. Jayawardena, Hyun-Soo Kim, K.K. Asanka Sanjeewa, Eui Joeng Han, Youngheun Jee, Ginnae Ahn, Jung-Rae Rho & You-Jin Jeon. (2021) Loliolide, isolated from Sargassum horneri; abate LPS-induced inflammation via TLR mediated NF-κB, MAPK pathways in macrophages. Algal Research 56, pages 102297.
Crossref
Crossref
Natalia Kovalova, Jeffrey Boyles, Yi Wen, Derrick R. Witcher, Patricia L. Brown‐Augsburger, Victor J. Wroblewski & Lukasz K. Chlewicki. (2020) Validation of a de‐immunization strategy for monoclonal antibodies using cynomolgus macaque as a surrogate for human. Biopharmaceutics & Drug Disposition 41:3, pages 111-125.
Crossref
Crossref
Jaspreet Jain, Vimal Narayanan, Ankit Kumar, Jatin Shrinet, Priyanshu Srivastava, Shivam Chaturvedi & Sujatha Sunil. (2019) Establishment and Comparison of Pathogenicity and Related Neurotropism in Two Age Groups of Immune Competent Mice, C57BL/6J Using an Indian Isolate of Chikungunya Virus (CHIKV). Viruses 11:6, pages 578.
Crossref
Crossref
Sevim Barbasso Helmers, Mei Bruton, Ingela Loell, Ann-Kristin Ulfgren, Alastair J Gracie, Iain B McInnes & Ingrid E Lundberg. (2018) Expression of interleukin-18 in muscle tissue of patients with polymyositis or dermatomyositis and effects of conventional immunosuppressive treatment. Rheumatology 57:12, pages 2149-2157.
Crossref
Crossref
Katerina Oikonomopoulou, Eleftherios P. Diamandis, Morley D. Hollenberg & Vinod Chandran. (2018) Proteinases and their receptors in inflammatory arthritis: an overview. Nature Reviews Rheumatology 14:3, pages 170-180.
Crossref
Crossref
Rachel Byng-Maddick, Carolin T. Turner, Gabriele Pollara, Matthew Ellis, Naomi J. Guppy, Lucy C. K. Bell, Michael R. Ehrenstein & Mahdad Noursadeghi. (2017) Tumor Necrosis Factor (TNF) Bioactivity at the Site of an Acute Cell-Mediated Immune Response Is Preserved in Rheumatoid Arthritis Patients Responding to Anti-TNF Therapy. Frontiers in Immunology 8.
Crossref
Crossref
X.‐L. Zhao, L.‐F. Tian, S.‐J. Zhang, J.‐M. Li, H. Feng, L.‐M. Wang, S. Wang, J. Wang, T. Wang & W.‐Q. Chen. (2016)
Novel Human Three‐Domain Antibody Fragments Against
sTNF
α
as Well as tm
TNF
α
with High Affinity Generated by the Combination of Ribosome Display and
E. coli
Expression System
. Scandinavian Journal of Immunology 83:4, pages 267-278.
Crossref
Crossref
Ariana Barlič, Sara Žigon, Andrej Blejec & Nevenka Kregar Velikonja. (2015) Gene expression of cultured human chondrocytes as a model for assessing neutralization efficacy of soluble TNFα by TNFα antagonists. Biologicals 43:3, pages 171-180.
Crossref
Crossref
Mei Zong, Christina Dorph, Maryam Dastmalchi, Helene Alexanderson, Jennifer Pieper, Petra Amoudruz, Sevim Barbasso Helmers, Inger Nennesmo, Vivianne Malmström & Ingrid E Lundberg. (2014) Anakinra treatment in patients with refractory inflammatory myopathies and possible predictive response biomarkers: a mechanistic study with 12 months follow-up. Annals of the Rheumatic Diseases 73:5, pages 913-920.
Crossref
Crossref
Kevin E. Kip, Jason M. Swoger, Lisa M. Grandinetti, Arthur M. BarrieIIIIII, Julia B. Greer & Miguel D. Regueiro. (2013) Tumor Necrosis Factor α Antagonist–associated Psoriasis in Inflammatory Diseases. Inflammatory Bowel Diseases 19:6, pages 1164-1172.
Crossref
Crossref
Bernard Combe. (2012) L’apport et les indications des biothérapies dans les rhumatismes inflammatoires. Bulletin de l'Académie Nationale de Médecine 196:7, pages 1279-1293.
Crossref
Crossref
Xavier Mariette. (2012) Les nouveautés physiopathologiques à la base de la révolution thérapeutique des biothérapies dans les rhumatismes inflammatoires. Bulletin de l'Académie Nationale de Médecine 196:7, pages 1261-1278.
Crossref
Crossref
Liang Tso Sun, Emily Friedrich, Joshua L. Heuslein, Rachel E. Pferdehirt, Nicole M. Dangelo, Shanmugasundaram Natesan, Robert J. Christy & Newell R. Washburn. (2012) Reduction of burn progression with topical delivery of (antitumor necrosis factor‐α)‐hyaluronic acid conjugates. Wound Repair and Regeneration 20:4, pages 563-572.
Crossref
Crossref
M Sisto, S Lisi, D D Lofrumento, M D'Amore, M A Frassanito & D Ribatti. (2012) Sjögren’s syndrome pathological neovascularization is regulated by VEGF-A-stimulated TACE-dependent crosstalk between VEGFR2 and NF-κB. Genes & Immunity 13:5, pages 411-420.
Crossref
Crossref
S. Bluml, C. Scheinecker, J. S. Smolen & K. Redlich. (2012) Targeting TNF receptors in rheumatoid arthritis. International Immunology 24:5, pages 275-281.
Crossref
Crossref
Kim Klaassen, Ivan Nyklíček, Simone Traa & Ron de Nijs. (2011) Distressed personality is associated with lower psychological well-being and life satisfaction, but not disability or disease activity in rheumatoid arthritis patients. Clinical Rheumatology 31:4, pages 661-667.
Crossref
Crossref
E. MeugnierF. CouryJ. TebibC. Ferraro-PeyretS. RomeJ. Bienvenu, H. VidalJ. Sibilia & N. Fabien. (2011) Gene expression profiling in peripheral blood cells of patients with rheumatoid arthritis in response to anti-TNF-α treatments. Physiological Genomics 43:7, pages 365-371.
Crossref
Crossref
Saliha KaratayFatih AkcayKadir YildirimFazile Hatipoglu ErdemFiliz Alp. (2011) Effects of Some Acupoints (Du-14, Li-11, St-36, and Sp-6) on Serum TNF-α and hsCRP Levels in Healthy Young Subjects. The Journal of Alternative and Complementary Medicine 17:4, pages 347-350.
Crossref
Crossref
Margherita Sisto, Sabrina Lisi, Dario D. Lofrumento, Simone Caprio, Vincenzo Mitolo & Massimo D’Amore. (2010) TNF blocker drugs modulate human TNF-α-converting enzyme pro-domain shedding induced by autoantibodies. Immunobiology 215:11, pages 874-883.
Crossref
Crossref
Margherita Sisto, Sabrina Lisi, Dario Domenico Lofrumento, Liana Cucci, Vincenzo Mitolo & Massimo D'Amore. (2010) Blockade of TNF-α signaling suppresses the AREG-mediated IL-6 and IL-8 cytokines secretion induced by anti-Ro/SSA autoantibodies. Laboratory Investigation.
Crossref
Crossref
Satoshi Hohki, Nobuyuki Ohguro, Hiroshi Haruta, Kei Nakai, Fumitaka Terabe, Satoshi Serada, Minoru Fujimoto, Shintaro Nomura, Hirohisa Kawahata, Tadamitsu Kishimoto & Tetsuji Naka. (2010) Blockade of interleukin-6 signaling suppresses experimental autoimmune uveoretinitis by the inhibition of inflammatory Th17 responses. Experimental Eye Research 91:2, pages 162-170.
Crossref
Crossref
Fei Hua, Peter V. Henstock & Betty Tang. (2010) ERK activation by GM-CSF reduces effectiveness of p38 inhibitor on inhibiting TNFα release. International Immunopharmacology 10:7, pages 730-737.
Crossref
Crossref
K.R. Rupesh, A. Moushumi Priya, B. Sundarakrishnan, R. Venkatesan, B.S. Lakshmi & S. Jayachandran. (2010) 2,2′-Bipyridyl based copper complexes down regulate expression of pro-inflammatory cytokines and suppress MAPKs in mitogen induced Peripheral blood mononuclear cells. European Journal of Medicinal Chemistry 45:6, pages 2141-2146.
Crossref
Crossref
Karine Labadie, Thibaut Larcher, Christophe Joubert, Abdelkrim Mannioui, Benoit Delache, Patricia Brochard, Lydie Guigand, Laurence Dubreil, Pierre Lebon, Bernard Verrier, Xavier de Lamballerie, Andreas Suhrbier, Yan Cherel, Roger Le Grand & Pierre Roques. (2010) Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages. Journal of Clinical Investigation 120:3, pages 894-906.
Crossref
Crossref
Sabrina Lisi & Margherita Sisto. (2009) Effects of biological drug adalimumab on tumour necrosis factor‐α‐converting enzyme activation. Immunology & Cell Biology 88:3, pages 297-304.
Crossref
Crossref
Christopher W. Espelin, Arthur Goldsipe, Peter K. Sorger, Douglas A. Lauffenburger, David de Graaf & Bart S. Hendriks. (2010) Elevated GM-CSF and IL-1β levels compromise the ability of p38 MAPK inhibitors to modulate TNFα levels in the human monocytic/macrophage U937 cell line. Molecular BioSystems 6:10, pages 1956.
Crossref
Crossref
M. Sisto, S. Lisi, D. D. Lofrumento, M. A. Frassanito, L. Cucci, S. D'Amore, V. Mitolo & M. D'Amore. (2009) Induction of TNF-alpha-converting enzyme-ectodomain shedding by pathogenic autoantibodies. International Immunology 21:12, pages 1341-1349.
Crossref
Crossref
Andreas Suhrbier & Suresh Mahalingam. (2009) The immunobiology of viral arthritides. Pharmacology & Therapeutics 124:3, pages 301-308.
Crossref
Crossref
E. Shantsila & G. Y. H. Lip. (2009) Systemic inflammation as a driver of vascular calcification: a proof of concept. Journal of Internal Medicine 266:5, pages 453-456.
Crossref
Crossref
Joaquín Borrás-Blasco, Andrés Navarro-Ruiz, Consuelo Borrás & Elvira Casterá. (2009) Adverse Cutaneous Reactions Induced by TNF-α Antagonist Therapy. Southern Medical Journal 102:11, pages 1133-1140.
Crossref
Crossref
Katia Varani, Alfonso Massara, Fabrizio Vincenzi, Alice Tosi, Melissa Padovan, Francesco Trotta & Pier Andrea Borea. (2009)
Normalization of A
2A
and A
3
adenosine receptor up-regulation in rheumatoid arthritis patients by treatment with anti-tumor necrosis factor α but not methotrexate
. Arthritis & Rheumatism 60:10, pages 2880-2891.
Crossref
Crossref
Nestor E. Rulli, Angelo Guglielmotti, Giorgina Mangano, Michael S. Rolph, Claudia Apicella, Ali Zaid, Andreas Suhrbier & Suresh Mahalingam. (2009) Amelioration of alphavirus-induced arthritis and myositis in a mouse model by treatment with bindarit, an inhibitor of monocyte chemotactic proteins. Arthritis & Rheumatism 60:8, pages 2513-2523.
Crossref
Crossref
Arthur Kavanaugh. (2009) Infection prophylaxis in antirheumatic therapy: emphasis on vaccination. Current Opinion in Rheumatology 21:4, pages 419-424.
Crossref
Crossref
Mee-Young Lee, Bo-Young Park, Ok-Kyoung Kwon, Ji-Eun Yuk, Sei-Ryang Oh, Hui-Seong Kim, Hyeong-Kyu Lee & Kyung-Seop Ahn. (2009) Anti-inflammatory activity of (−)-aptosimon isolated from Daphne genkwa in RAW264.7 cells. International Immunopharmacology 9:7-8, pages 878-885.
Crossref
Crossref
T. Yoshimura, K.-H. Sonoda, N. Ohguro, Y. Ohsugi, T. Ishibashi, D. J. Cua, T. Kobayashi, H. Yoshida & A. Yoshimura. (2009) Involvement of Th17 cells and the effect of anti-IL-6 therapy in autoimmune uveitis. Rheumatology 48:4, pages 347-354.
Crossref
Crossref
L Jiang, X F Wei, D H Yi, P Xu, H Liu, Q Chang, S M Yang, Z F Li, H B Gao & G J Hao. (2009) Synergistic effects of cyclic strain and Th1-like cytokines on tenascin-C production by rheumatic aortic valve interstitial cells. Clinical and Experimental Immunology 155:2, pages 216-223.
Crossref
Crossref
F. Montecucco & F. Mach. (2008) Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis. Rheumatology 48:1, pages 11-22.
Crossref
Crossref
Debjani Sarkar, Piu Saha, Sunita Gamre, Surajit Bhattacharjee, Chellaram Hariharan, Sudipto Ganguly, Rupashree Sen, Goutam Mandal, Subrata Chattopadhyay, Subrata Majumdar & Mitali Chatterjee. (2008) Anti-inflammatory effect of allylpyrocatechol in LPS-induced macrophages is mediated by suppression of iNOS and COX-2 via the NF-κB pathway. International Immunopharmacology 8:9, pages 1264-1271.
Crossref
Crossref
Augusto A. Litonjua & Diane R. Gold. (2008) Asthma and obesity: Common early-life influences in the inception of disease. Journal of Allergy and Clinical Immunology 121:5, pages 1075-1084.
Crossref
Crossref